Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
Navidea Biopharmaceuticals收到書面通知，稱紐約證券交易所決心啓動公司股票退市程序；公司董事會將對啓動退市程序的決定提出上訴
Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings
Navidea Biopharmaceuticals收到書面通知，稱紐約證券交易所決心啓動公司股票退市程序；公司董事會將對啓動退市程序的決定提出上訴
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。